ChemicalBook >> CAS DataBase List >>Tolterodine tartrate

Tolterodine tartrate

CAS No.
124937-52-6
Chemical Name:
Tolterodine tartrate
Synonyms
DETROL;Detrol LA;TOLTERODINE L-TARTRATE;olterodine tartrate;CS-452;DETRUSITOL;PNU-20058E;PNU-200583E;TOLERODINETARTRATE;Tolterodine(Detrol)
CBNumber:
CB0320588
Molecular Formula:
C26H37NO7
Molecular Weight:
475.57
MDL Number:
MFCD07771985
MOL File:
124937-52-6.mol
Last updated:2023-08-28 18:13:45

Tolterodine tartrate Properties

Melting point 205-210°C
alpha 54625 +36.0°
storage temp. Sealed in dry,2-8°C
solubility Methanol (Sparingly), Water (Slightly)
form Solid
pka 9.87(at 25℃)
color White to Off-White
BCS Class 1
CAS DataBase Reference 124937-52-6(CAS DataBase Reference)
FDA UNII 5T619TQR3R

Pharmacokinetic data

Protein binding 96%
Excreted unchanged in urine <1%
Volume of distribution 0.9-1.6(L/kg)
Biological half-life 12 / -

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictograms
GHS08,GHS09
Signal word  Warning
Hazard statements  H361d-H411
Precautionary statements  P201-P202-P273-P280-P308+P313-P391
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-37/39
RIDADR  UN 2811 6.1 / PGIII
HS Code  29222990
Toxicity LD50 i.v. in male mice: 10-20 mg/kg (Jnsson)
NFPA 704
0
2 0

Tolterodine tartrate price More Price(48)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich Y0001697 Tolterodine for system suitability European Pharmacopoeia (EP) Reference Standard 124937-52-6 Y0001697 $223 2024-03-01 Buy
Sigma-Aldrich Y0001696 Tolterodine tartrate European Pharmacopoeia (EP) Reference Standard 124937-52-6 Y0001696 $223 2024-03-01 Buy
Sigma-Aldrich SML3034 Tolterodine L-tartrate ≥98% (HPLC) 124937-52-6 10MG $89 2024-03-01 Buy
Sigma-Aldrich SML3034 Tolterodine L-tartrate ≥98% (HPLC) 124937-52-6 50MG $359 2024-03-01 Buy
Sigma-Aldrich PHR1891 Tolterodine Tartrate Pharmaceutical Secondary Standard: Certified Reference Material 124937-52-6 500MG $342 2024-03-01 Buy
Product number Packaging Price Buy
Y0001697 Y0001697 $223 Buy
Y0001696 Y0001696 $223 Buy
SML3034 10MG $89 Buy
SML3034 50MG $359 Buy
PHR1891 500MG $342 Buy

Tolterodine tartrate Chemical Properties,Uses,Production

Chemical Properties

White-to-Off-White Crystalline Powder

Originator

Detrol,Pharmacia and Upjohn

Uses

Tolterodine (tartrate) is a competitive antagonist of muscarinic (M) receptors (Ki = 1.4, 2.7, 3.6, 3.1, and 2.2 nM for M1 through M5, respectively). Antagonists of muscarinic receptors, including tolterodine, are effective in treating overactive bladder symptoms.[Cayman Chemical]

Uses

A muscarinic receptor antagonist. Used in the treatment of urinary incontinence.

Uses

Tolterodine tartrate (Detrol LA) is a tartrate salt of tolterodine that is a competitive muscarinic receptor antagonist. Tolterodine tartrate (Detrol LA) is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urge

Manufacturing Process

Trans-cinnamic acid (100 g, 675 mmol) is added to a 1 L 4-neck round bottom flask equipped with a mechanical stirrer, thermocouple, and nitrogen inlet. Para-cresol (76.6 g, 708 mmol) is preheated in a water bath at 60°C and added to the cinnamic acid followed by concentrated sulfuric acid (13.0 ml, 243 mmol). The reaction is immediately heated to a set point of 122.5°C and stirred at 120°-125°C until judged to be complete by HPLC analysis. When the reaction is complete the mixture is cooled to 100°C and added to a prewarmed separatory funnel (500 ml). The bottom layer containing the sulfuric acid is removed and toluene (280 ml), water (50 ml) and potassium carbonate (47%, 10 ml) are added to the separatory funnel containing the crude product. The pH of the aqueous layer is adjusted to between 5-8 with additional 47% potassium carbonate. The layers are separated and the organic layer is then washed once with water (50 ml). The organic layer is concentrated to a final volume of approximately 150 ml under reduced pressure. Isopropanol (350 ml) is then added, and distillation is continued to a volume of 350 ml. Isopropanol (150 ml) is again added and again distilled to 350 ml (2 times). The mixture is then cooled to 30°-40°C with rapid stirring until the product crystallizes. The rapid stirring is continued after crystallization. The product is cooled to 0°-5°C and held at this temperature for 1 h, filtered and washed with isopropanol (200 ml) cooled to 0°-5°C. If the last portion of the wash is colored the wash is continued until no more color is removed. The solids are then dried at 60°C under reduced pressure to give the 3,4-dihydro-6-methyl-4-phenyl-2H-benzopyran-2-one, melting point (uncorrected) 83°-85°C.
3,4-Dihydro-6-methyl-4-phenyl-2H-benzopyran-2-one (100.0 g, 420.2 mmol) is added to toluene (500 ml). The mixture is degassed by purging alternately with vacuum and nitrogen and then cooled to -21°C. Diisobutylaluminum hydride in toluene solution (DIBAL, 1.5 M, 290 ml, 435 mmol) is then slowly added over 2 h via add funnel while maintaining the reaction temperature at - 20°-25°C. The reaction is usually done when the DIBAL add is completed. If the reaction is not done additional DIBAL can be added in increments. When the reaction is done (<1% lactone) ethyl acetate (45 ml) is added at -20°- 25°C via add funnel. Very little exotherm is observed. Next, citric acid (23%, 500 ml) is added. The mixture is stirred at 45°-50°C for 1 h (or stirred overnight at 20°-25°C), the phases are separated, the organic phase is washed with water (2 times 300 ml). The organic phase is concentrated to 250 ml under reduced pressure. Methanol (500 ml) is added, and the mixture is concentrated to 250 ml. The methanol addition and distillation is repeated to give the 3,4-dihydro-6-methyl-4-phenyl-2H-benzopyran-2-ol in methanol solution.
3,4-Dihydro-6-methyl-4-phenyl-2H-benzopyran-2-ol in methanol (500 ml) is slowly added to palladium on carbon (5%, 22 g, 1.5 mmol) while maintaining a slight nitrogen purge. If 3,4-dihydro-6-methyl-4-phenyl-2H-benzopyran-2-ol is added too quickly without a nitrogen purge the catalyst will ignite the methanol. Diisopropylamine (147.0 ml, 1.05 mol) is added, and the mixture is hydrogenated at 45-50 psi and 48°C until the reaction is judged to be complete by HPLC (<2% lactol). The reaction is usually done after 10 h, but can be run overnight. The reaction mixture is cooled and removed from the hydrogenator using a methanol (150 ml) rinse. The combined reaction mixture and rinse is filtered through a bed of solka floc (10 g). The solka floc is washed thoroughly with methanol (100 ml) and the filtrate is concentrated to remove methanol while ethyl acetate is being added back. The volume of this solution of the (2-diisopropylamino)ethyl)benzyl)-p-cresol is adjusted to 700 ml using ethyl acetate and the mixture is heated to 55°C. To form the hydrochloride salt of the (2-diisopropylamino)ethyl)benzyl)-p_x0002_cresol (Tolterodine), concentrated hydrochloric acid (52.5 ml, 630 mmol) is added over 15 min. The resulting slurry is gradually cooled to -15°-20°C and held at this temperature for 1 h. Tolterodine hydrochloride is collected by filtration, washed 3 times with ethyl acetate, and dried overnight under reduced pressure at 600 to give the tolterodine hydrochloride, melting point 199°-201°C. Tolterodine hydrochloride (130.0 g, 359 mmol), methylene chloride (1.3 L) and water (650 ml) are mixed. The mixture is stirred rapidly while adding sodium hydroxide (50%, 13.0 ml) and sodium carbonate (13.0 g, 123 mmol). The pH as determined by pH paper is 10-11. After stirring thoroughly for approximately 15 min two clear homogeneous phases form. Stirring is continued for another 45 min, the layers are separated and the organic phase is washed with water (2 times 650 ml). The methylene chloride mixture is concentrated under reduced pressure. The concentrate is dissolved in ethanol (325 ml) and warmed to 60°-70°C. L-tartaric acid (80.84 g, 539 mmol) slurried in hot ethanol (810 ml) is added via add funnel at 60°-70°C over approximately 30 min. When the addition is done the slurry is refluxed for 1 h, gradually cooled to 0°C and held at this temperature for 1 h. The slurry is filtered, washed with ethanol (2 times 260 ml) previously cooled to 0°C, and dried overnight under reduced pressure at 60°C to give the crude title compound. The crude product (136.0 g) and ethanol (5.44 L) are mixed and heated to 80°C for 30 min. The mixture is concentrated to half the initial volume by distilling 2.72 L of ethanol. The mixture is gradually cooled to 20°- 25°C over 1 h, placed in an ice bath, and held at 0°C for 1 h. The tolterodine L-tartrate is collected by filtration, washed with ethanol (2 times 272 ml ) previously cooled to 0°C, and dried overnight under reduced pressure at 60°C to give product. This procedure was repeated a second time on 81.0 g of once recrystallized tolterodine L-tartrate to give the optically active (+)-(R)-2-(α- (2-(diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate, melting point (uncorrected)=210°-211°C.

Therapeutic Function

Anticholinergic

General Description

Tolterodine Tartrate is a tertiary muscarinic?antagonist, basically used to manage urinary frequency, urgency, and incontinence in detrusor instability.

Biological Activity

tolterodine tartrate (detrol la) is a tartrate salt of tolterodine that is a competitive muscarinic receptor antagonist.

Clinical Use

Selective vasopressin V2 -receptor antagonist:
Treatment of hyponatraemia secondary to SIADH
To slow the progression of autosomal dominant polycystic kidney disease (ADPKD)

Drug interactions

Potentially hazardous interactions with other drugs
Anti-arrhythmics: increased risk of ventricular arrhythmias with amiodarone, disopyramide and flecainide; increased risk of antimuscarinic side effects with disopyramide.
Antifungals: avoid concomitant use with itraconazole and ketoconazole.
Antivirals: avoid concomitant use with fosamprenavir, indinavir, lopinavir, ritonavir and saquinavir.
Beta-blockers: increased risk of ventricular arrhythmias with sotalol.

Metabolism

Metabolised mainly by the cytochrome P450 isoenzyme CYP3A4. Eliminated mainly by the faecal route

Global( 382)Suppliers
Supplier Tel Email Country ProdList Advantage
Hebei Mojin Biotechnology Co., Ltd
+8613288715578 sales@hbmojin.com China 12453 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971 deasea125996@gmail.com China 2503 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21695 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714 fandachem@gmail.com China 9352 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Jinan Shengqi pharmaceutical Co,Ltd
86+18663751872 christine@shengqipharm.com CHINA 491 58
Accela ChemBio Inc.
(+1)-858-699-3322 info@accelachem.com United States 19965 58
Hebei Guanlang Biotechnology Co., Ltd.
+86-19930503282 alice@crovellbio.com China 8822 58
HubeiwidelychemicaltechnologyCo.,Ltd
18627774460 faith@widelychemical.com CHINA 742 58

View Lastest Price from Tolterodine tartrate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Tolterodine tartrate pictures 2023-08-29 Tolterodine tartrate
124937-52-6
US $0.00 / KG 1KG 99% 50000KG/month Hebei Mojin Biotechnology Co., Ltd
Tolterodine tartrate pictures 2023-07-29 Tolterodine tartrate
124937-52-6
US $30.00 / kg 1kg 99% 1000tons Henan Bao Enluo International TradeCo.,LTD
Tolterodine tartrate pictures 2023-02-13 Tolterodine tartrate
124937-52-6
US $35.00 / kg 1kg 99% 50MT Hebei baicao biology science and technology co., ltd
  • Tolterodine tartrate pictures
  • Tolterodine tartrate
    124937-52-6
  • US $35.00 / kg
  • 99%
  • Hebei baicao biology science and technology co., ltd

Tolterodine tartrate Spectrum

PNU-200583E (±)-Tolterodine-d14 Tartrate Tolterodine tartrate (Detrol LA) R-(+)-N,N-Diisopropyl-3-(2-hydroxy-5- Methylphenyl)-3-phenylpropylaMine L-Tartarte R-(+)-Toltaridine L-Tartrate Tolterodine Tartaric Acid Tolterodine Tartrate API Rac-tolterodine tartrate-D14 Tolterodine(Detrol) 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol(2R,3R)-2,3-dihydroxybutanedioate (S)-2-(3-(diisopropylaMino)-1-phenylpropyl)-4-Methylphenol (2R,3R)-2,3-dihydroxysuccinate (R)-2-(3-(DiisopropylaMino)-1-phenylpropyl)-4-Methylphenol (2R,3R)-2,3-dihydroxysuccinate 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-phenol, (2R,3R)-2,3-dihydroxybutanedioate (1:1) Tolterodine tartrate (+)-R)-2-{a-[2-(Diisopropylamino)ethyl]benzyl}-p-cresol tartrate Tolterodine (as Tartrate) DETRUSITOL TOLTERODINE TARTRATE (+)-(R)-2-[A-[2-(DIISOPROPYLAMINO) ETHYL]BENZYL]-P-CRESOL TARTRATE PNU-20058E (R)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol L-Tartrate (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrate R-(+)-N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine, PNU-20058E, Detrol, Detrusitol, R-(+)-Toltaridine TOLERODINETARTRATE (+)-R)-2-{a-[2-(Diisopropylamino)ethyl]benzyl}-p-cresol tartrate (R)-2-(3-(DIISOPROPYLAMINO)-1-PHENYLPROPYL)-4-METHYLPHENOL 2,3-DIHYDROXYSUCCINATE (R)-2-(3-DIISOPROPYLAMINO-1-PHENYL-PROPYL)-P-CRESOL L-TARTRATE (R)-2-(3-Diisopropylamino-1-phenyl-propyl)-p- CS-452 tolteradine tartrate Tolterodine tartrate CRS Tolterodine for system suitability Tolterodine tartrate USP/EP/BP Tolterodine tartrate (Kabi-2234 Tolterodine Tartrate D14 Tolterodine TartrateQ: What is Tolterodine Tartrate Q: What is the CAS Number of Tolterodine Tartrate Q: What is the storage condition of Tolterodine Tartrate Q: What are the applications of Tolterodine Tartrate TIANFU CHEM 124937-52-6 Tolterodine tartrate Tolterodine Tartrate (1671480) Detrol LA DETROL TOLTERODINE L-TARTRATE olterodine tartrate Toterodine tartrate Azvudine Impurity 18 124937-52-6 124937-52-5 C22H31NOC4H6O6 C26H37NO7 C22H31NOC4H6O6C26H37NO7 C22H31NOxC4H6O6 C22H31NOC4H6O6C26H37N Detrol LA, Kabi-2234, PNU-200583E APIs Medicine intermediate Active Pharmaceutical Ingredients In treatment of urinary incontinence Inhibitors Intermediates & Fine Chemicals Pharmaceuticals